SMAD3 and Hepatic fibrosis: Moreover, Zhang and his colleagues used magnolol to prevent the interaction between SMAD3 and SMAD4 and, thus, could attenuate TGF-β signaling and concanavalin A induced hepatic fibrosis [265].